CN110530993B - Improved detection method of deacetylated hairy glycoside related substance - Google Patents

Improved detection method of deacetylated hairy glycoside related substance Download PDF

Info

Publication number
CN110530993B
CN110530993B CN201910814398.5A CN201910814398A CN110530993B CN 110530993 B CN110530993 B CN 110530993B CN 201910814398 A CN201910814398 A CN 201910814398A CN 110530993 B CN110530993 B CN 110530993B
Authority
CN
China
Prior art keywords
mobile phase
impurity
hairy
impurities
deacetyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910814398.5A
Other languages
Chinese (zh)
Other versions
CN110530993A (en
Inventor
杨易可
程燕
梁屹
张帆
陈小林
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanghai Xudong Haipu Pharmaceutical Co ltd
Original Assignee
Shanghai Xudong Haipu Pharmaceutical Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Xudong Haipu Pharmaceutical Co ltd filed Critical Shanghai Xudong Haipu Pharmaceutical Co ltd
Priority to CN201910814398.5A priority Critical patent/CN110530993B/en
Publication of CN110530993A publication Critical patent/CN110530993A/en
Application granted granted Critical
Publication of CN110530993B publication Critical patent/CN110530993B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/26Conditioning of the fluid carrier; Flow patterns
    • G01N30/28Control of physical parameters of the fluid carrier
    • G01N30/34Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The invention discloses an improved analysis method for detecting related substances of deacetyl hairy flower glycoside, which comprises the following steps of adopting a reversed phase C18 column and taking water as a mobile phase A; the volume ratio is 20: 16-24: 14, taking acetonitrile-methanol as a mobile phase B; the temperature of the chromatographic column is 25-35 ℃, the detection wavelength is 200-270 nm, the flow rate is 0.8-1.5 ml/min, and gradient elution is carried out.

Description

Improved detection method of deacetylated hairy glycoside related substance
Technical Field
The invention belongs to the technical field of medicines, relates to a method for analyzing and detecting a medicine, and particularly relates to a method for detecting deacetyl hairy flower glycoside and related substances thereof.
Background
In the research and development of new drugs or imitation drugs, impurities are key quality attributes affecting products. The structure, physicochemical property and toxicity of impurities are complex, so the examination and research of related substances are one of the difficulties in drug development. The adverse reaction generated in the clinical use process of the medicine is not only related to the pharmacological activity of the main component, but also is closely indistinguishable from the influence of impurities. In order to ensure safe clinical medication, impurities in the medicine must be strictly controlled.
Deacetyl hairy flower glycoside, EnglishThe name of the product is Deslanoside, the chemical name is 3- [ [ O-beta-D-glucopyranosyl- (1 → 4) -O-2, 6-dideoxy-beta-D-ribo-hexopyranosyl]Oxo radical]-12, 14-dihydroxy-cardol-20 (22) -enolide with molecular formula of C47H74O19Molecular weight 943.09, CAS number 17598-65-1, structural formula as follows:
Figure BDA0002185932800000011
an injection of desacetylhairy flower glycoside, which is sold as cedilan, is an antiarrhythmic drug and is mainly used for heart failure. Because of its fast action, it is suitable for patients with acute cardiac insufficiency or acute exacerbation of chronic cardiac insufficiency, and can be used for controlling the ventricular rate of patients with atrial fibrillation and atrial flutter accompanied by fast ventricular rate, and sometimes for stopping supraventricular tachycardia and its slow action.
The related substances in the desacetylhairoside injection can be derived from two aspects, process impurities and degradation impurities, wherein the structures of part of the process impurities and the degradation impurities are determined as shown in table 0:
table 0: summary of deacetyl hairy glycoside hybrid mass spectrometry
Figure BDA0002185932800000021
Figure BDA0002185932800000031
According to the literature search, in the methods for detecting the deacetylated hairy flower glycoside and related substances, the thin-layer chromatography is adopted in foreign pharmacopoeias such as European pharmacopoeia and Japanese pharmacopoeia, and the content of the related substances is difficult to accurately detect. The method of the Chinese pharmacopoeia 2015 adopts a high performance liquid chromatography method, and uses octadecylsilane chemically bonded silica as a filling agent; taking water as a mobile phase A; acetonitrile-methanol (22: 14) is used as a mobile phase B; the detection wavelength was 220nm and the gradient elution was performed as in Table 1.
TABLE 1 examination method of related substance of deacetyl hairy flower glycoside
Figure BDA0002185932800000032
The high performance liquid chromatography of the Chinese pharmacopoeia 2015 for detecting related substances of the desacetyleriocitrin is more accurate than the thin-layer chromatography, but still has some defects, such as incapability of detecting all impurities, poor separation degree, limited separation capacity and detection capacity of the impurities, and further improvement on the quality control of products. Therefore, a more applicable detection method for the deacetylated hairy flower glycoside related substances is urgently needed to be found.
Disclosure of Invention
Aiming at the technical problems in the prior art, the invention provides an improved method for detecting the deacetyl hairy flower glycoside and related substances, and the method for separating and determining the deacetyl hairy flower glycoside related substances in the patent application solves the technical problems that the method for determining the deacetyl hairy flower glycoside related substances in the prior art is low in detection capability and inaccurate.
The invention provides an improved method for separating and measuring related substances of deacetyl hairy flower glycoside, which comprises the following steps: adopting a reversed-phase high performance liquid chromatograph; adopting a reversed phase C18 column, and taking water as a mobile phase A; and (2) mixing the components in a volume ratio of 20: 16-24: performing gradient elution by using acetonitrile-methanol of 14 as a mobile phase B; the temperature of the chromatographic column is 25-35 ℃, the detection wavelength is 200-270 nm, and the flow rate is 0.8-1.5 ml/min; (ii) a
Preferably, the gradient elution is preferably as follows:
0-25 min, and 67% of mobile phase A; 26-26 min, reducing the mobile phase A from 67% to 60%; 26-38 min, wherein the mobile phase A is 60%; reducing the content of the mobile phase A from 60% to 45% in 38-39 min; 39-50 min, wherein the content of the mobile phase A is 45%, and 50-51 min, the content of the mobile phase A is increased from 45% to 67%; then the equilibration continued for 5min at 67% mobile phase a.
Preferably, the column is Agilent ZORBAX SB C18, more preferably, the inner diameter of the column is 4.6mm x 250mm and the packing particle size is 3.5 μm.
Preferably, the column temperature is 30 ℃.
Preferably, the detection wavelength is 220 nm.
Preferably, the flow rate is 1.0 ml/min.
Preferably, the mobile phase B is a mixture of 20: 16 solution of acetonitrile and methanol.
The invention has the following beneficial effects: the novel detection method for related substances of the desacetylhairoside has the advantages of high detection rate of related substances, high precision, good repeatability and recovery rate, control over 5 key known impurities and 5 key unknown impurities, guarantee of the quality of the desacetylhairoside and final products of injection thereof, and implementation of the concept that the quality is derived from design in actual production. The method can detect more impurities, particularly can detect the impurities C and E, can ensure the separation degree among peaks, and sets the limit of key impurities according to the detection results of each batch during detection, thereby greatly improving the economic applicability in the actual production process.
Drawings
FIG. 1 is a map of the applicability of the system of example 1 of the present invention;
FIG. 2 is a graph of a test solution of example 1 of the present invention;
FIG. 3 is a map of comparative example 1 of the present invention.
Detailed Description
The following embodiments of the present invention will be described in further detail with reference to the accompanying drawings, and it should be understood that the embodiments are described for better understanding of the technical scheme of the present application, but not for limitation of the technical scheme of the present application, and any combination of the above impurities and the deacetylated hairy flower glycoside isolated and determined by the method of the present invention falls within the scope of the present invention.
Example 1 System applicability
The instrument comprises the following steps: waters e2695/2489 high performance liquid chromatograph
A chromatographic column: agilent ZORBAX SB C18(4.6 mm. times.250 mm, 3.5 μm)
Mobile phase A: water (W)
Mobile phase B: acetonitrile-methanol (20: 16, v/v)
The flow rate is 1.0 ml/min;
the temperature of the chromatographic column is 30 ℃;
the detection wavelength is 220 nm;
the sample amount is 20 mul;
gradient elution was performed according to the gradient shown in table 2:
TABLE 2 gradient elution
Time (minutes) Mobile phase A (%) Mobile phase B (%)
0 67 33
25 67 33
26 60 40
38 60 40
39 45 55
50 45 55
51 67 33
56 67 33
Preparing a system applicability test solution: precisely weighing appropriate amount of each of the deacetyl hairy flower glycoside, the impurity F reference substance, the impurity G reference substance, the impurity H reference substance, the impurity C reference substance and the impurity E reference substance, dissolving the solution in a solvent, and diluting to prepare a solution containing about 0.2mg of the deacetyl hairy flower glycoside, about 7 mu G of the impurity F, about 4 mu G of the impurity G, H and about 1 mu G of the impurity C, E per 1ml of the solution to be used as a system applicability test solution.
Blank solution (diluent): acetonitrile: methanol: water 232: 148: 620 (volume ratio).
Preparing a test solution: collecting the injection containing desacetylhairoside.
Preparation of a control solution: precisely measuring 1ml of the test solution, placing the test solution in a 100ml measuring flask, diluting the test solution to the scale, and shaking up to obtain a control solution (1%).
And (3) determination: respectively taking blank solvent, system applicability solution, control solution and sample solution 20 μ l, respectively, injecting into high performance liquid chromatograph, and recording chromatogram. The results are as follows: see table 3, system suitability map see fig. 1; the profile of the control solution is shown in FIG. 2
TABLE 3 Deacetyllanatoside and related substance separation
Figure BDA0002185932800000061
Figure BDA0002185932800000071
As a result: the blank solvent has no interference to the determination, and the peak emergence order is impurity F peak, impurity G peak, deacetyl hairy flower glycoside peak, impurity H peak, impurity C peak and impurity E peak. The minimum separation degree between each impurity peak and the main component of the deacetyl hairy flower glycoside and between each impurity peak is 2.01 (the separation degree is more than or equal to 1.5); it follows that the results meet the system suitability requirements.
Example 2 detection and quantitation limits
Experimental conditions, liquid chromatography methods and solution preparation As shown in example 1, solutions can also be prepared according to methods known to those skilled in the art.
For known impurities: diluting the impurity solution with known concentration and the deacetyl hairy glycoside solution to lower concentration, comparing the measured signal with a baseline signal (baseline noise), and taking the corresponding concentration of the known impurity with the signal-to-noise ratio s/n responding to an instrument being more than or equal to 10 as the quantitative limit of the method; the corresponding concentration of the lowest response in the known impurities at the signal-to-noise ratio s/n of more than or equal to 3 on the instrument is the detection limit of the method.
For unknown impurities: the main component of the deacetyl hairy flower glycoside is used for replacing the quantitative limit concentration and the detection limit concentration for examining a single unknown impurity.
The test results are shown in Table 4.
TABLE 4 determination of detection limit and quantitation limit for impurity F
Figure BDA0002185932800000072
The detection limit of the impurity F is 0.0094 mu g/ml, and the quantification limit is 0.0312 mu g/ml; the detection limit of the impurity G is 0.0225 mug/ml, and the quantification limit is 0.0749 mug/ml; the detection limit of the deacetyl hairy flower glycoside is 0.0587 mu g/ml, and the quantification limit is 0.1956 mu g/ml; the detection limit of the impurity H is 0.0587 mu g/ml, and the quantification limit is 0.1955 mu g/ml; the detection limit of the impurity C is 0.0573 mug/ml, and the quantification limit is 0.1910 mug/ml; the detection limit of the impurity E is 0.0587 mu g/ml, and the quantification limit is 0.1956 mu g/ml.
Example 3 linearity
Experimental conditions, liquid chromatography methods and solution preparation As in example 1, solutions can also be prepared according to methods well known to those skilled in the art.
For known impurities, 6 concentration points were taken in the range from the LOQ (limit of quantitation of LOQ) concentration to the index concentration of not less than 150% and studied. The linear relationship is plotted as a function of the measured response signal (peak area) versus analyte concentration, and a linear regression is performed using a least squares method, with at least the correlation coefficient R being reported2To verify a good linear relationship, it is required that the coefficient should be between 0.990 and 1.000.
For unknown impurities, the linearity and range of the unknown impurities are examined by using a deacetyl hairy flower glycoside sample instead.
The linear relationship and the results of the analysis of each substance are shown in tables 5 to 10
1. Impurity F
TABLE 5 Linear measurement of impurity F
Figure BDA0002185932800000081
The linear equation is Y-43634.2577X + 521.6178; the linear regression coefficient R is in the range of 0.0312 mug/ml to 12.4640 mug/ml21.0000, good linearity;
2. impurity G
TABLE 6 Linear measurement of impurity G
Figure BDA0002185932800000091
The linear equation is Y-33860.3698X-139.3229; linear regression coefficient R in the range of 0.0749-7.4940 mug/ml21.0000, good linearity;
3. deacetylhairy flower glycoside
TABLE 7 Linear assay of Deacetyllanatoside
Figure BDA0002185932800000092
The linear equation is Y-18434.3624X-101.6787; linear regression coefficient R in the range of 0.1956-7.8780 mug/ml2Is 1.0000, the linearity is good.
4. Impurity H
TABLE 8 Linear measurement of impurity H
Figure BDA0002185932800000101
The linear equation is Y-26880.9022X-124.0079; linear regression coefficient R in the range of 0.1955-7.8200 mug/ml2Is 1.0000, the linearity is good.
5. Impurity C
TABLE 9 Linear measurement of impurity C
Figure BDA0002185932800000102
The linear equation is Y-16753.1000X-18.1579; linear regression coefficient R in the range of 0.1910-1.9100 mug/ml20.9999, the linear relationship is good.
6. Impurity E
TABLE 10 Linear measurement of impurity E
Figure BDA0002185932800000111
The linear equation is Y-22687.4996X + 86.7337; linear regression coefficient R in the range of 0.1956-1.9560 mug/ml2Is 1.0000, the linearity is good.
Comparative example 1: chromatographic method for measuring related substances of deacetyl hairy flower glycoside injection in Chinese pharmacopoeia 2015 edition
Detection solution: the test solution of example 1 was used
The instrument comprises the following steps: waters e2695/2489 high performance liquid chromatograph
A chromatographic column: agilent ZORBAX SB C18(4.6 mm. times.250 mm, 3.5 μm)
Mobile phase A: water (W)
Mobile phase B: acetonitrile-methanol (22: 14, v/v)
The flow rate is 1.0 ml/min; the column temperature is 30 ℃; the detection wavelength is 220 nm; the sample amount is 20 mul;
gradient elution, the elution procedure is: as set forth in the table below,
Figure BDA0002185932800000112
Figure BDA0002185932800000121
as shown in a chromatogram recorded in figure 3, the peak position of the impurity C, E in the method is on the slope, the impurity cannot be detected, the unknown impurities in F, G and 6.282min are very close, and when the chromatographic conditions are slightly changed, the separation degree of the impurities is poor, so that the detection result is influenced.
It will be apparent to those skilled in the art that various changes and modifications may be made in the present invention without departing from the spirit and scope of the invention. Thus, if such changes and modifications of the present invention fall within the scope of the claims of the present invention and their equivalents, the present invention is intended to include such changes and modifications.

Claims (4)

1. An improved detection method of related substances of deacetyl hairy flower glycoside is characterized by comprising the following steps of adopting a reversed-phase high performance liquid chromatograph; the temperature of a chromatographic column is 25-35 ℃, the detection wavelength is 200-270 nm, the flow rate is 0.8-1.5 ml/min, a reversed-phase C18 chromatographic column is adopted, and the reversed-phase C18 chromatographic column is Agilent ZORBAX SB C18, 4.6mm is multiplied by 250mm, and 3.5 mu m; taking water as a mobile phase A; the volume ratio is 20: performing gradient elution by using 16 acetonitrile-methanol as a mobile phase B; the gradient elution was as follows:
time (minutes) Mobile phase A (%) Mobile phase B (%) 0 67 33 25 67 33 26 60 40 38 60 40 39 45 55 50 45 55 51 67 33 56 67 33
The related substances comprise five known impurities and any one or more of five unknown impurities, and the five known impurities have the following structures:
Figure FDA0003459389800000011
Figure FDA0003459389800000021
2. the method of claim 1, wherein the column temperature is 30 ℃.
3. The detection method according to claim 1, wherein the detection wavelength is 220 nm.
4. The assay of claim 1, wherein the flow rate is 1.0 ml/min.
CN201910814398.5A 2019-08-30 2019-08-30 Improved detection method of deacetylated hairy glycoside related substance Active CN110530993B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910814398.5A CN110530993B (en) 2019-08-30 2019-08-30 Improved detection method of deacetylated hairy glycoside related substance

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910814398.5A CN110530993B (en) 2019-08-30 2019-08-30 Improved detection method of deacetylated hairy glycoside related substance

Publications (2)

Publication Number Publication Date
CN110530993A CN110530993A (en) 2019-12-03
CN110530993B true CN110530993B (en) 2022-03-15

Family

ID=68665476

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910814398.5A Active CN110530993B (en) 2019-08-30 2019-08-30 Improved detection method of deacetylated hairy glycoside related substance

Country Status (1)

Country Link
CN (1) CN110530993B (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961326A (en) * 2012-11-27 2013-03-13 上海朝晖药业有限公司 Preparation method of deslanoside injection
CN104447933A (en) * 2014-12-22 2015-03-25 成都倍特药业有限公司 Synthesis method for medical-grade deslanoside
CN107118248A (en) * 2017-05-27 2017-09-01 成都倍特药业有限公司 A kind of process for purification of high-purity Deslanoside
CN109734768A (en) * 2019-02-01 2019-05-10 桂林医学院 Go acetyl cedilanid glucosyl group modified compound composite lipidosome and its application

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102961326A (en) * 2012-11-27 2013-03-13 上海朝晖药业有限公司 Preparation method of deslanoside injection
CN104447933A (en) * 2014-12-22 2015-03-25 成都倍特药业有限公司 Synthesis method for medical-grade deslanoside
CN107118248A (en) * 2017-05-27 2017-09-01 成都倍特药业有限公司 A kind of process for purification of high-purity Deslanoside
CN109734768A (en) * 2019-02-01 2019-05-10 桂林医学院 Go acetyl cedilanid glucosyl group modified compound composite lipidosome and its application

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
A sensitive method for digoxin determination using formate-adduction based on the effect of ionization enhancement in liquidchromatograph–mass spectrometer;Xia Li 等;《Journal of Chromatography B》;20141211;第138-144页 *
HPLC法测定去乙酰毛花苷注射液的含量及其有关物质;侯玉荣 等;《药学与临床研究》;20080630(第03期);第239页第2.1节 *
十三种洋地黄属强心试成分的反相高效液相分离;朱雾虹 等;《药学学报》;19871231;第22卷(第07期);第524-520页 *
去乙酰毛花苷注射液的杂质研究;李舸远 等;《药学与临床研究》;20111231(第06期);第508-509页第2.2-2.3节、第510页图5 *
微柱HPLC法测定洋地黄毒甙片和去乙酰毛花甙C注射液中的强心甙;翁凌勇;《国外医学.药学分册》(第02期);第126-127页 *

Also Published As

Publication number Publication date
CN110530993A (en) 2019-12-03

Similar Documents

Publication Publication Date Title
CN106814150B (en) Isotope dilution ultra-performance liquid chromatography-mass spectrometry combined vitamin K determination method1Method (2)
CN115453012B (en) Reversed-phase HPLC method for simultaneously measuring multiple positional isomers in voathixetine hydrobromide
CN115060832B (en) Method for detecting contents of oxcarbazepine and preservatives in oxcarbazepine oral suspension
CN111766317A (en) Method for measuring GS-441524 content in preparation by using polyethylene glycol and water
CN111679010B (en) High performance liquid chromatography detection method for Ruideciclovir intermediate GS-441524
CN110530993B (en) Improved detection method of deacetylated hairy glycoside related substance
CN115166125A (en) Method for rapidly determining concentration of eltrombopag in human plasma by adopting ultra-high performance liquid chromatography-tandem mass spectrometry
CN114965742A (en) Method for determining vitamin K1 drop-related substances
CN110095554B (en) Method for analyzing milrinone related substances by high performance liquid chromatography
CN113640403A (en) Content detection method of pazufloxacin mesilate bulk drug
CN114264765A (en) Analysis method for determining related substances in glimepiride intermediate by using HPLC
CN114544842A (en) Method for detecting N-bromosuccinimide in voriconazole
CN117147736B (en) Detection method of D-glucose-delta-lactone related substance
CN115856167A (en) Detection method of digoxin-related substances
CN112014479A (en) Method for detecting n-valeryl chloride in valsartan
CN108802211B (en) Liquid phase detection method for related substances in cefquinome sulfate breast injectant
CN116539765B (en) Method for detecting related substances of teprenone capsules
CN110873761A (en) Gas chromatography detection method for escitalopram oxalate intermediate related substances
CN112595793B (en) Earthworm injection detection method based on phenol determination
CN114778730B (en) Method for simultaneously detecting 6 organic acids in aster medicinal material or aster product
CN115097040B (en) UPLC characteristic spectrum construction method and application of semen momordicae
CN113686999B (en) High performance liquid chromatography detection method for aniline residues in saccharide compounds
CN109030642B (en) Method for measuring dehydrophenylalsteine analogue and isomer thereof
CN113533598B (en) High performance liquid chromatography analysis method for content of scutellaria baicalensis in infantile lung heat cough and asthma granules
CN113189239B (en) Method for determining content of pellets I in dexlansoprazole sustained-release capsule by high performance liquid chromatography

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant